Wim Blendeman

M&F Worldwide Corp. operates as a holding company with interests in manufacturing licorice and check products. The company was founded in 1988 and is headquartered in New York, NY.

MacAndrews & Forbes Holdings, Inc. (MacAndrews & Forbes) is a private equity firm founded in 1984 by Ronald Perelman. The firm is headquartered in New York.

Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege.

Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ.

Jewish Board of Family & Children's Services, Inc. is a non-profit company that provides website hosting services. The company is based in New York, NY. The company has over 25 years of experience and offer a variety of web hosting plans with 99.9% server uptime. The company's services are supported by 24/7 technical support from real employees.

PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Part of Sanofi, Genzyme Flanders BVBA is a Belgian company that develops and manufactures biotherapeutic products. The company is based in Geel, Belgium.

Catalent France Limoges SAS manufactures pharmaceutical preparations. The company is headquartered in Limoges, France.

Catalent France Beinheim SA is engaged in softgel development and manufacturing operations. It offers formulation development and manufacturing services for controlled substances, highly potent compounds, and hormones. The firm’s technologies include optiform® solution suite, optigel™ bio, and rp scherer softgel technology. The company was founded on May 3, 1965 and is headquartered in Beinheim, France.

BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium.

Part of Catalent, Inc., Catalent Germany Eberbach GmbH is a company that manufactures and supplies soft gel and pharmaceutical products. The company is based in Eberbach, Germany. The CEOs are Steven Lawrence Fasman, Aristippos Gennadios, Raoul Bernhardt. The company was founded in 2012.

MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium.

Pneumo Abex LLC engages in the provision of asbestos related friction products. The company was founded in 2004 and is headquartered in Camden, NJ.

CELL MATTERS SA offers solutions for cryopreserving cells. Its products include Cooling and Warming kit designed to cryopreserve by vitrification process. The company was founded by Delphine Connan, Fabien Ectors and Luc Grobet on June 12, 2017 and is headquartered in Liege, Belgium.

Founded in 1980, Catalent Micron Technologies Ltd. is a subsidiary of Catalent, Inc. The company is based in Swindon, UK. The British company provides contract development and manufacturing services, delivery technologies, and manufacturing solutions for pharmaceuticals, biologics, and consumer health products.

Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018.